Meru Health validated by Validation Institute for significant healthcare savings
The Validation Institute, a trusted third-party organization dedicated to bringing greater transparency and accountability to healthcare, rigorously reviewed Meru Health's outcomes data. The review examined medical claims data from more than 1,300 Meru Health participants between 2021 and 2023 and compared results against a nationally representative matched group.
Key findings
- Lower costs: Broadly the Meru Health program participants PMPM was lower than non-program participants
- Chronic condition impact: The program showed strong savings across key subgroups. Participants with cardiac conditions saved
$122.93 PMPM, those with diabetes saved$163.38 PMPM, and participants with cancer achieved the largest advantage at$557.58 PMPM. - Broad benefit: Across multiple chronic condition groups, participants consistently demonstrated stronger cost performance compared to matched non-participants.
Delivering better outcomes through whole-person care
"We are proud to receive this validation from the Validation Institute, which highlights the measurable impact Meru Health delivers to patients and payers alike," said
Meru Health's validation underscores its commitment to transparency, accountability, and proven outcomes in mental healthcare.
To review the full Validation Institute report, visit: https://validationinstitute.com/mp-files/meru_health_Savings_2025_final.pdf/
About Meru Health
Meru Health offers convenient access to an app-based program with unlimited therapist support and daily practices to improve your mental health, nutrition, breath, sleep, and more. The program achieves superior results compared to traditional cognitive behavioral therapy or antidepressant treatments. Meru Health partners with major health insurance providers like Cigna and Aetna. For more information, visit www.meruhealth.com.
View original content:https://www.prnewswire.com/news-releases/meru-health-validated-by-validation-institute-for-significant-healthcare-savings-302542193.html
SOURCE Meru Health
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Anbogen Therapeutics and The University of Tokyo Enter Collaborative Research Agreement to Evaluate ABT-301 Across Multiple Tumor Types, Targeting Accelerated Human Clinical Indication Expansion
- AG.AL Crowned Esports World Cup 2026 Club Champion After Landmark Competition in Paris
- Top Meme Coin To Buy: Pipedog Selling Persists Despite 3,294% APY as AlphaPepe Stage 20 Keeps Filling
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share